Chapter 9: Infection

Opportunistic pathogens like Clostridium difficile and Candida albicans demonstrate how normally benign or controlled organisms can become dangerous when host barriers are compromised or immunosuppression occurs. The infection process unfolds through sequential stages: initial encounter and transmission via direct contact, indirect routes, vertical transmission, or zoonotic pathways; colonization of host tissues; invasion through pathogen virulence mechanisms; dissemination throughout the body; and tissue damage through various mechanisms. Pathogens have evolved sophisticated strategies to evade host defenses, including toxin production, antioxidant generation, immunoglobulin degradation, antigenic mimicry, antigenic variation, and biofilm formation on medical devices that confers antibiotic resistance. The chapter details clinical infection stages—incubation, prodromal, invasive, and convalescence phases—and explains pathogen-immune interactions at each stage. Comprehensive coverage of bacterial infections addresses gram-positive and gram-negative organisms, examining virulence factors such as pili, flagella, polysaccharide capsules, hydrolytic enzymes, exotoxins, and endotoxins, with emphasis on severe outcomes like sepsis and septic shock mediated by inflammatory cytokines. Viral infections are explained through replication mechanisms, latency establishment, and examples including influenza with its antigenic drift and shift phenomena, herpesviruses, human immunodeficiency virus, human papillomavirus, respiratory syncytial virus, and hepatitis viruses, along with cytopathic effects ranging from cell lysis to oncogenic transformation. Fungal infections span superficial dermatophyte infections, cutaneous candidiasis, subcutaneous sporotrichosis, systemic dimorphic fungi, and opportunistic organisms affecting immunocompromised patients. Parasitic infections encompass protozoal pathogens and helminths with varied transmission mechanisms. The chapter concludes by addressing two critical global health challenges: antimicrobial resistance through enzymatic degradation, efflux pump mechanisms, target alteration, and horizontal gene transfer, exemplified by methicillin-resistant Staphylococcus aureus and drug-resistant tuberculosis; and vaccination strategies employing active immunization with antigens to generate protective immunity versus passive immunotherapy using preformed antibodies for immediate but temporary protection.